Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
not assigned
|
| gptkbp:class |
amphetamine
psychedelic benzodifuran |
| gptkbp:describedBy |
gptkb:PiHKAL
|
| gptkbp:duration |
8-12 hours
|
| gptkbp:firstSynthesized |
gptkb:Alexander_Shulgin
|
| gptkbp:hasMolecularFormula |
C20H24N2O2
|
| gptkbp:hasPsychoactiveEffects |
psychedelic
|
| gptkbp:hasReportedDosage |
15-25 mg (oral)
|
| gptkbp:hasReportedEffects |
empathy
euphoria visual enhancement altered thinking |
| https://www.w3.org/2000/01/rdf-schema#label |
DSP-22
|
| gptkbp:isStructurallyRelatedTo |
gptkb:2C-B
2C-B-FLY Bromo-DragonFLY |
| gptkbp:IUPACName |
2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethan-1-amine
|
| gptkbp:legalStatus |
uncontrolled (most countries)
|
| gptkbp:relatedTo |
gptkb:2C-B
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Delta_IV_program
|
| gptkbp:bfsLayer |
7
|